Life sciences and health care companies represent the largest industry in the U.S. economy. Given the importance of this sector, the demand for financial evaluation both in public and private companies. At the same time, an accurate assessment is particularly difficult in view of the transfer of business models, the modern economy, intellectual property rights issues, continuous innovation in the industry, the changing demographics of the population, the quality and state involvement in health care debate, discussion and regulation. Here we consider the changing and increasingly problematic assessment of the life sciences and health care companies, which have obvious relevance to the social welfare point of view. "Hide
by Carol W. Cardin, Travis Chamberlain, John W. Hill Source: Business Horizons 15 pages. Publication Date: March 15, 2010. Prod. #: BH379-PDF-ENG
Related Case Solutions & Analyses:
Michael Rubens Bloomberg
Washington Mutuals Covered Bonds
Vitreon Corp.: The Hyalite Project
Professional Services Course
Jewellworld.com: Leading Web-Based IT Development in the Jewellery Industry
Managing Individual Human Capital: Research Resources
Marketing Planning at Just Us! Cafes
SGFE Cambodia (A): High-energy Char Briquettes for the Bottom of the Pyramid
The Armenia Earthquake
A COUPLE OF SQUARES: PRICING FOR THE FUTURE
